Bei Wang

Dr. Bei Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2017 in Science
Verified
Journal Article
Closed access
PDF file
DHDongran Han
Dongran Han
XQXiaodong Qi
Xiaodong Qi
CMCameron Myhrvold
Cameron Myhrvold
BWBei Wang
Bei Wang
MDMingjie Dai
Mingjie Dai
PYPeng Yin
Peng Yin
Large origami from a single strand: Nanostructures created by origami-like folding of nucleic acids are usually formed by base-pairing interactions between multiple strands. Han et al. show that large origami (up to 10,000 nucleotides for DNA and 6000 nucleotides for RNA) can be created in simple shapes, such as a rhombus or a heart. A single strand can be folded smoothly into structurally complex but knot-free structures by using partially complemented double-stranded DNA and the cohesion of parallel crossovers. The use of single strands also enables in vitro synthesis of these structures. Science , this issue p. eaao2648

2 April 2025 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
XCXuanyi Cai
Xuanyi Cai
YZYunan Zhang
Yunan Zhang
MSMeng Su
Meng Su
FCFan Chang
Fan Chang
LQLei Quan
Lei Quan
BWBei Wang
Bei Wang
The Chinese version of the Symptom Checklist-90 (SCL-90) is excessively lengthy, resulting in extended completion time and reduced respondent compliance. This study aimed to utilize a condensed subset of items from the Chinese SCL-90 to identify individuals at high risk for psychological disorders based on machine learning methods, forming a concise and efficient preliminary psychopathological screening instrument for the Chinese general population. Analyzing data collected from 4808 SCL-90 psychological surveys, this study applied variable clustering to select the most representative items, resulting in an 11-item scale: the Chinese Symptom Checklist-11 (CSCL-11). The CSCL-11 demonstrated high internal consistency (Cronbach’s α = 0.84). The results of factor analysis supported a single-factor model for the CSCL-11, demonstrating an acceptable fit (SRMR = 0.035, RMSEA = 0.064, CFI = 0.935, and TLI = 0.919). The CSCL-11 demonstrated strong predictive performance for the Global Severity Index (GSI; RMSE = 0.11, R2 = 0.92, Pearson’s r = 0.96) and various subscale scores (RMSE < 0.25, R2 > 0.70, Pearson’s r > 0.85). Additionally, it achieved a 96% accuracy rate in identifying individuals at high risk for psychological disorders. The comparison results indicated that the CSCL-11 outperformed SCL-14, SCL-K11, and SCL-K-9 in predicting GSI scores. In identifying high-risk groups, CSCL-11 demonstrated performance similar to that of SCL-14 and surpassed both SCL-K11 and SCL-K-9. The CSCL-11 retains most of the critical information from the original Chinese SCL-90 and serves as a preliminary psychopathological screening tool for the Chinese general population.

Verified
Journal Article
Open access
PDF file
BWBei Wang
Bei Wang
YLYulin Li
Yulin Li
YLYixing Liu
Yixing Liu
DHDongran Han
Dongran Han
Metabolic syndrome (MetS) has been associated with migraine, but the prediagnostic phase and the molecular features preceding migraine onset remain unclear. We aimed to identify a diagnosis-anchored proteomic variability window and to characterize pathways, candidate bridge proteins, and druggable targets within a direction-consistent MetS-to-migraine molecular framework. We first assessed the association between baseline MetS and incident migraine in 452,471 UK Biobank participants using Cox models. We then conducted a nested proteomics case–control analysis stratified by MetS status and applied single-sample Jensen–Shannon divergence (sJSD), network proximity, directed diffusion, and drug–target proximity analyses. Baseline MetS was associated with a higher risk of incident migraine (hazard ratio 1.09, 95% confidence interval (CI) 1.01–1.18; p = 0.022). A diagnosis-anchored proteomic divergence pattern peaked 4.71–6.76 years before migraine diagnosis in the MetS stratum. The parallel within-stratum analysis in the NoMetS stratum showed no T2-centered peak. We identified 11 direction-consistent novel pathways, seven candidate bridge proteins spanning metabolic, endothelial, and brain tissues, and three candidate drugs. These findings support a diagnosis-stratified framework for studying MetS-related migraine and provide testable hypotheses for future mechanistic and pharmacological evaluation.